| View |
|
DRP-10963-02
|
Etoricoxib
|
Ebicox
|
90 mg
|
Film-Coated Tablet
|
Non-steroidal Anti-Inflammatory Drug (Selective COX-2 Inhibitor)
|
Acme Formulation Pvt. Ltd
|
India
|
CLIDP Conversion
|
30 March 2023
|
23 December 2026
|
| View |
|
DRP-10963-03
|
Etoricoxib
|
Etoricass-90
|
90 mg
|
Film-Coated Tablet
|
Non-steroidal Anti-inflammatory Drug (Selective COX-2 Inhibitor)
|
Acme Formulation Pvt. Ltd
|
India
|
CLIDP Conversion
|
05 September 2023
|
23 December 2026
|
| View |
|
DRP-10962-01
|
Etoricoxib
|
Ebicox
|
120 mg
|
Film-Coated Tablet
|
Non-steroidal Anti-Inflammatory Drug (Selective COX-2 Inhibitor)
|
Acme Formulation Pvt. Ltd
|
India
|
CLIDP Conversion
|
30 March 2023
|
23 December 2026
|
| View |
|
DRP-10963-01
|
Etoricoxib
|
Roxigen-90
|
90mg
|
Film-Coated Tablet
|
Non-steroidal Anti-Inflammatory Drug (Selective COX-2 Inhibitor)
|
Acme Formulation Pvt. Ltd
|
India
|
CLIDP Conversion
|
31 December 2022
|
23 December 2026
|
| View |
|
DRP-10926-02
|
Hydroxyethyl Starch + Sodium Chloride
|
Volugen
|
60 mg/ 9 mg per mL (6 g / 900 per 100mL) (6% w/v / 0.9% w/v)
|
Solution for Injection (IV Infusion)
|
Plasma Expander/Blood Substitute
|
Aroma ?laç San. Ltd. ?ti
|
Turkey
|
CLIDP Conversion
|
30 March 2023
|
17 December 2026
|
| View |
|
DRP-12921-01
|
Co-Amoxiclav
|
Genbac CV
|
312.5 mg/5 mL
|
Powder for Oral Suspension ( Orange Flavor)
|
Antibacterial (Penicillin + Beta-Lactamase Inhibitor)
|
Yeluri Formulations Pvt. Ltd.
|
India
|
CLIDP Conversion
|
13 April 2023
|
28 October 2027
|
| View |
|
DRP-12921-03
|
Co-Amoxiclav
|
Bacticox 250
|
312.5 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial (Penicillin + Beta-Lactamase Inhibitor)
|
Yeluri Formulations Pvt Ltd.
|
India
|
CLIDP Conversion
|
10 June 2024
|
28 October 2027
|
| View |
|
DRP-12458-01
|
Lactulose
|
Aelac
|
3.35 g/5 ml
|
Oral Solution
|
Osmotically Acting Laxative
|
PANACEA BIOTEC PHARMA LIMITED
|
India
|
CLIDP Conversion
|
05 May 2023
|
12 August 2027
|
| View |
|
DRP-13474-01
|
Vildagliptin
|
Rivida
|
50 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DDP-4) Inhibitor
|
Eskayef Pharmaceuticals Limited
|
Bangladesh
|
CLIDP Conversion
|
10 May 2023
|
27 February 2028
|
| View |
|
DRP-11636-01
|
Amlodipine (as besilate)
|
Genvasc-10
|
10 mg
|
Tablet
|
Calcium Channel Blocker
|
Ratnatris Pharmaceutical Pvt. Ltd
|
India
|
CLIDP Conversion
|
10 June 2023
|
04 April 2027
|
| View |
|
DRP-5924-2
|
Clarithromycin
|
Clariset-250
|
250 mg per 5 mL
|
Granules for Suspension
|
Antibacterial
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
31 May 2023
|
05 January 2025
|
| View |
|
DRP-5932-2
|
Clarithromycin
|
Clariset-125
|
125 mg / 5 mL
|
Granules for Oral Suspension
|
Antibacterial (Macrolide)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
31 May 2023
|
21 February 2027
|
| View |
|
DRP-8746-03
|
Cefuroxime (as sodium)
|
Gofurox
|
1. 5 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
10 May 2023
|
20 February 2025
|
| View |
|
DRP-8746-02
|
Cefuroxime (as sodium)
|
Jaxime 1.5
|
1. 5 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
|
CLIDP Conversion
|
31 March 2023
|
20 February 2025
|
| View |
|
DRP-8746-04
|
Cefuroxime (as sodium)
|
Cefatex
|
5 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
22 July 2023
|
20 February 2025
|
| View |
|
DRP-8746-06
|
Cefuroxime (as sodium)
|
Cefulev 1.5
|
1.5 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
11 June 2024
|
20 February 2025
|
| View |
|
DRP-15217
|
Sitagliptin (as hydrochloride monohydrate)
|
Kozta
|
100 mg
|
Film-Coated Tablet
|
Dipeptidyl peptidase 4 (DPP-4) Inhibitor
|
Sag Manufacturing, S.L.U.
|
Spain
|
Initial
|
29 May 2024
|
29 May 2029
|
| View |
|
BRP-140
|
Diphtheria and Tetanus Vaccine (Adsorbed)
|
None
|
Formulation:
Each dose (0.5 mL) contains:
Diphtheria Toxoid -2 Lf (30 IU)
Tetanus Toxoid -7.5 Lf (40 IU).
Aluminum phosphate*-1.5 mg
Thiomersal*- 0.05 mg
*Aluminum phosphate and Thiomersal, used as an adjuvant and a preservative, respectively.
|
Suspension For Injection (IM)
|
Vaccines
|
PT. Biofarma (Persero)
|
Indonesia
|
Initial
|
30 May 2024
|
30 May 2029
|
| View |
|
DRP-15219
|
Cefoperazone (as sodium)
|
Cefonov
|
1g
|
Powder for Injection (IM/IV)
|
Antibacterial (Third-generation Cephalosporin)
|
Finebiotics Pharma Ltd..
|
India
|
Initial
|
29 May 2024
|
29 May 2029
|
| View |
|
DRP-15212
|
Tramadol Hydrochloride
|
Aralev
|
50 mg
|
Dispersible Tablet
|
Opioid Analgesic
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Initial
|
29 May 2024
|
29 May 2029
|